Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.81)
# 86
Out of 5,058 analysts
24
Total ratings
76.47%
Success rate
45.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics | Maintains: Equal-Weight | $8 → $11 | $15.57 | -29.35% | 3 | Nov 11, 2025 | |
| ZYME Zymeworks | Maintains: Equal-Weight | $15 → $17 | $22.99 | -26.05% | 2 | Nov 7, 2025 | |
| RLAY Relay Therapeutics | Maintains: Equal-Weight | $4 → $6 | $6.51 | -7.83% | 1 | Nov 7, 2025 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $60 | $38.06 | +57.65% | 1 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Overweight | $25 → $29 | $20.19 | +43.64% | 4 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Equal-Weight | $95 → $97 | $95.80 | +1.25% | 5 | Sep 30, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $42 → $45 | $41.28 | +9.01% | 3 | Sep 25, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $67 → $70 | $70.58 | -0.82% | 1 | Sep 11, 2025 | |
| XNCR Xencor | Maintains: Overweight | $33 → $27 | $16.02 | +68.54% | 3 | Aug 7, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $44 | $33.71 | +30.53% | 1 | Jun 26, 2025 |
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $15.57
Upside: -29.35%
Zymeworks
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $15 → $17
Current: $22.99
Upside: -26.05%
Relay Therapeutics
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $4 → $6
Current: $6.51
Upside: -7.83%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $38.06
Upside: +57.65%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25 → $29
Current: $20.19
Upside: +43.64%
Merus
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $95 → $97
Current: $95.80
Upside: +1.25%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42 → $45
Current: $41.28
Upside: +9.01%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67 → $70
Current: $70.58
Upside: -0.82%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33 → $27
Current: $16.02
Upside: +68.54%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $33.71
Upside: +30.53%